Midgard Science

Labs / Assays & in vitro testing

GlyProVac ApS

Odense, Denmark · glyprovac.com

On your own

Free. Their own email.

Contact GlyProVac ApS directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

GlyProVac ApS develops pre-clinical bacterial subunit vaccine candidates using its proprietary BEMAP technology. The company focuses on vaccines against bacterial infections linked to antimicrobial resistance, with work centered on E. coli and urinary tract infections.

They take quote requests by email.

What they offer

  • Bacterial vaccine discovery platform

    Develops novel bacterial subunit vaccine candidates based on the proprietary BEMAP platform.

  • BEMAP sample enrichment for O-linked glycosylation

    Uses a mass spectrometry-based enrichment method to identify O-linked protein glycosylations.

  • Antigen discovery for bacterial pathogens

    Identifies glycosylated bacterial protein targets relevant to pathogenesis and vaccine development.

What they work on

Modalities
Peptide, Vaccine
Species and models
E. coli, Pseudomonas aeruginosa, Shigella, Enterotoxigenic Escherichia coli (ETEC)
Assays and studies
mass spectrometry, sample enrichment, O-linked glycosylation identification
Instruments and platforms
titanium dioxide
Therapeutic areas
antimicrobial resistance, urinary tract infections, bacterial infections
Founded
2007

Similar labs. Aurigene Pharmaceutical Services, Bioneeds, Creative Biolabs, Devsynthesis

Found in a contract services directory. Listing built from glyprovac.com. Work here? Claim this listing.

GlyProVac ApS · Midgard Science